There is a real opportunity for pharma to support the under-served population of atopic dermatitis patients, writes Mariel Metcalfe.
Mariel Metcalfe
Advertisement
Mariel Metcalfe (marielm@researchpartnership.com) is Head of Living With at Research Partnership.
Articles by Mariel Metcalfe
Advertisement
Latest Updated Articles
Atopic Dermatitis — Going Beyond the PillPublished: April 23rd 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
